“Just do the buyback already like practically any other company that announces a buyback does.”
seriously what is wrong with this guy?
Why is there so much secrecy, and stupidity, and obfuscation, and not doing the hard work that needs to be done?
2 decades of inaction and this type of BS is why we’re in this insane position of frustration and uncertainty in 2025. We should be having our very own GLP1 moment, only ten years ago!
If the next manager doesn’t kick to the curb wolgrins lacklustre self serving time squandering business model for one that fully promotes the incredible benefits that the safe and effective skin tanning drug will give UVR vulnerable skin types , combined with some honesty and exposure of the anti sunlight anti skin tan issues that are ruining this great drugs incredible potential………… we are SCREWED!
- Forums
- ASX - By Stock
- CUV
- Ann: Notification regarding unquoted securities - CUV
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
0.20%
!
$9.81

Ann: Notification regarding unquoted securities - CUV, page-4
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$9.81 |
Change
-0.020(0.20%) |
Mkt cap ! $491.7M |
Open | High | Low | Value | Volume |
$9.89 | $9.99 | $9.66 | $899.3K | 91.51K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | $9.76 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.84 | 1739 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 9.760 |
1 | 110 | 9.740 |
1 | 246 | 9.720 |
1 | 246 | 9.710 |
3 | 2310 | 9.700 |
Price($) | Vol. | No. |
---|---|---|
9.840 | 1739 | 2 |
9.860 | 246 | 1 |
9.870 | 246 | 1 |
9.890 | 246 | 1 |
9.910 | 511 | 1 |
Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |